Aldatu Biosciences

Boston, United States Founded: 2014 • Age: 12 yrs
Diagnostic tools for infectious diseases are developed using genotyping platforms.
Annual revenue - Latest available
Total funding - 8 rounds
Employees - Tracked headcount
Investors 3 Known backers
Products 4 Services tracked
Competitors 11 Brand Intelligence

About Aldatu Biosciences

Aldatu Biosciences is a company based in Boston (United States) founded in 2014. Aldatu Biosciences offers products and services including PANDAA Platform, SARS-CoV-2 Tests, HIV Drug Resistance Tests, and Lassa Virus Detection. Aldatu Biosciences operates in a competitive market with competitors including BioLife Solutions, Sino Biological, GenScript, OncoDNA and Fluent BioSciences, among others.

  • Headquarter Boston, United States
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Aldatu Biosciences, Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    $3 M (USD), Grant

    Sep 12, 2022

  • Investors
    NIH

    & 2 more

  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Aldatu Biosciences

Aldatu Biosciences offers a comprehensive portfolio of products and services, including PANDAA Platform, SARS-CoV-2 Tests, HIV Drug Resistance Tests, and Lassa Virus Detection.

Product name locked
Category locked
Primary

Adaptive PCR system for detecting viral variants in infectious diseases

Product name locked
Category locked
Locked

Assays for detection and genotyping of SARS-CoV-2 variants

Product name locked
Category locked
Locked

Tests for identifying drug-resistant HIV variants

Product name locked
Category locked
Locked

PCR-based tests for detecting Lassa virus

People of Aldatu Biosciences

Headcount 10-50
Employee Profiles 12
Board Members and Advisors 2
Employee Profiles
People
Betsy Wonderly Trainor
VP Development
People
Mike Henry
Chief Business Officer
People
Larry Carrasco
Vice President Operations
People
Iain MacLeod
Co-Founder, CEO & CSO

Unlock access to complete

Funding Insights of Aldatu Biosciences

Investors in Aldatu Biosciences

Aldatu Biosciences has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include NIH, HHS and SBIR.

All
Institutional
Investor Description Founded Year Domain Location
Drug discovery services are provided to the biopharma sector.
Locked Locked Locked
Public health and human services are overseen by HHS.
Locked Locked Locked
Federal innovation and scientific achievement services are provided.
Locked Locked Locked
Premium access

Investor details for Aldatu Biosciences

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Aldatu Biosciences

Investments
Premium access

Investment portfolio details for Aldatu Biosciences

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Aldatu Biosciences

Premium access

Detailed financials for Aldatu Biosciences

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Aldatu Biosciences Comparisons

Aldatu Biosciences Primary company
Description
Diagnostic tools for infectious diseases are developed using...
Location
Boston, United States
Founded Year
2014
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Aldatu Biosciences

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Aldatu Biosciences

Aldatu Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioLife Solutions, Sino Biological, GenScript, OncoDNA and Fluent BioSciences, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Tissue hypothermic storage and cryopreservation freeze media are developed.
Locked Locked Locked
Reagents and kits are provided for clinical research applications.
Locked Locked Locked
Reagents and instruments are provided for life sciences research.
Locked Locked Locked
Genomic and theranostic services for oncology precision medicine are delivered.
Locked Locked Locked
Proprietary reagents for single-cell genetic analysis are developed.
Locked Locked Locked
Speech recognition solutions are provided by Inscripta for healthcare professionals.
Premium access

Detailed competitors of Aldatu Biosciences

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Aldatu Biosciences

Premium access

Complete news archive for Aldatu Biosciences

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aldatu Biosciences

Aldatu Biosciences was founded in 2014 and raised its 1st funding round 1 year after it was founded.

Aldatu Biosciences is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.

Aldatu Biosciences was founded in 2014 in Boston, United States, within the biotechnology sector. Operations center on the development of diagnostic solutions for infectious diseases, leveraging the proprietary PANDAA platforma modified qPCR protocolfor detecting HIV drug resistance in patient samples. A 1.5 million grant from the NIH was awarded in March 2015 to support test advancement. The domain aldatubio.com is utilized for online presence.

Aldatu Biosciences's top competitors include Sino Biological, OncoDNA and RoosterBio.

Aldatu Biosciences offers PANDAA Platform, SARS-CoV-2 Tests, HIV Drug Resistance Tests, and Lassa Virus Detection.

Aldatu Biosciences has 3 investors. Key investors include NIH, HHS, and SBIR.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available